1. Home
  2. QUBT vs VKTX Comparison

QUBT vs VKTX Comparison

Compare QUBT & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QUBT
  • VKTX
  • Stock Information
  • Founded
  • QUBT 2001
  • VKTX 2012
  • Country
  • QUBT United States
  • VKTX United States
  • Employees
  • QUBT N/A
  • VKTX N/A
  • Industry
  • QUBT Computer Manufacturing
  • VKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • QUBT Technology
  • VKTX Health Care
  • Exchange
  • QUBT Nasdaq
  • VKTX Nasdaq
  • Market Cap
  • QUBT 2.7B
  • VKTX 2.8B
  • IPO Year
  • QUBT N/A
  • VKTX 2015
  • Fundamental
  • Price
  • QUBT $18.65
  • VKTX $28.11
  • Analyst Decision
  • QUBT Strong Buy
  • VKTX Buy
  • Analyst Count
  • QUBT 1
  • VKTX 12
  • Target Price
  • QUBT $22.00
  • VKTX $84.00
  • AVG Volume (30 Days)
  • QUBT 38.2M
  • VKTX 3.7M
  • Earning Date
  • QUBT 05-15-2025
  • VKTX 07-23-2025
  • Dividend Yield
  • QUBT N/A
  • VKTX N/A
  • EPS Growth
  • QUBT N/A
  • VKTX N/A
  • EPS
  • QUBT N/A
  • VKTX N/A
  • Revenue
  • QUBT $385,000.00
  • VKTX N/A
  • Revenue This Year
  • QUBT $91.42
  • VKTX N/A
  • Revenue Next Year
  • QUBT $114.29
  • VKTX N/A
  • P/E Ratio
  • QUBT N/A
  • VKTX N/A
  • Revenue Growth
  • QUBT 45.83
  • VKTX N/A
  • 52 Week Low
  • QUBT $0.35
  • VKTX $18.92
  • 52 Week High
  • QUBT $27.15
  • VKTX $81.73
  • Technical
  • Relative Strength Index (RSI)
  • QUBT 56.48
  • VKTX 47.76
  • Support Level
  • QUBT $16.44
  • VKTX $23.80
  • Resistance Level
  • QUBT $18.43
  • VKTX $28.85
  • Average True Range (ATR)
  • QUBT 2.26
  • VKTX 1.65
  • MACD
  • QUBT -0.25
  • VKTX -0.02
  • Stochastic Oscillator
  • QUBT 49.82
  • VKTX 42.70

About QUBT Quantum Computing Inc.

Quantum Computing Inc is an integrated photonics and quantum optics technology company that provides accessible and affordable quantum machines to the world today. Its products are designed to operate at room temperature and low power at an affordable cost. The Company's portfolio of core technologies and products offer capabilities in the areas of high-performance computing, artificial intelligence, and cybersecurity, as well as remote sensing applications.

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Share on Social Networks: